Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on February 14, 20242/14/24
Excel in Market Access Success: Key Considerations for Leveraging Your Evidence
Posted on January 30, 20241/30/24
Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act
Posted on January 22, 20241/22/24
Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival
Posted on January 22, 20241/22/24
EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review
Posted on January 15, 20241/15/24
HemGenix Shines in Collaborative ITC Analysis: EVERSANA and CSL Behring Propel Gene Therapy to the Forefront in Hemophilia B Treatment
Posted on August 25, 20238/25/23
Unlocking Global Success: The Crucial Role of Integrated HEOR Programs in New Product Launches
Posted on May 16, 20235/16/23
Critical Success Factors for Launching Products with Fast Track, PRIME, or ILAP Designation
Posted on April 17, 20234/17/23